Pediapharm Inc. (CVE:PDP – Get Free Report) shot up 1.7% during trading on Friday . The stock traded as high as C$0.31 and last traded at C$0.30. 26,000 shares were traded during trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The company has a 50 day simple moving average of C$0.30 and a 200 day simple moving average of C$0.30. The company has a quick ratio of 0.71, a current ratio of 1.12 and a debt-to-equity ratio of 186.87. The stock has a market cap of C$66.36 million and a price-to-earnings ratio of -4.11.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Featured Stories
- Five stocks we like better than Pediapharm
- What is MarketRank™? How to Use it
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- How to invest in marijuana stocks in 7 steps
- How AI Implementation Could Help MongoDB Roar Back in 2025
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
